camostat
A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.
Classification
Chemical structure
| Molecular formula | C20H22N4O5 |
|---|---|
| Charge | 0 |
| Average mass | 398.419 Da |
| Monoisotopic mass | 398.15902 Da |
| Source | ChEBI |
| InChIKey | XASIMHXSUQUHLV-UHFFFAOYSA-N |
CN(C)C(=O)COC(=O)Cc1ccc(OC(=O)c2ccc(NC(=N)N)cc2)cc1
InChI=1S/C20H22N4O5/c1-24(2)17(25)12-28-18(26)11-13-3-9-16(10-4-13)29-19(27)14-5-7-15(8-6-14)23-20(21)22/h3-10H,11-12H2,1-2H3,(H4,21,22,23)
Also called
- camostatum
- 4-{2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate
- 4-{2-[(dimethylcarbamoyl)methoxy]-2-oxoethyl}phenyl 4-carbamimidamidobenzoate
- N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)phenylacetate
Cross-references
Drug registries
Patents and articles
Activity roles
- anticoronaviral agent
CHEBI:149553 - antiviral agent
CHEBI:22587
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:135632 |
camostat | antibioticmech:chebi-9c6db2e7c7 |
2026-08-30 |
Molecular targets
host-serine-protease-dependent influenza hemagglutinin activation BIOLOGICAL_PROCESS DOWNSTREAM_AFFECTED_PROCESS
Mechanism summary
- Mode of action
- VIRAL_ENTRY_INHIBITION host shared target
Record-level evidence
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
REVIEWED
Verified exact ChEBI identity, structure, antiviral and protease-inhibitor roles, and class; added host-protease-dependent viral-entry inhibition while preserving the study's unresolved individual-protease boundary.
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories